Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients.
about
Granulocyte-colony stimulating factors as adjunctive therapy for diabetic foot infectionsGranulocyte-colony stimulating factors as adjunctive therapy for diabetic foot infectionsGranulocyte-colony stimulating factors as adjunctive therapy for diabetic foot infectionsEffect of granulocyte colony-stimulating factor in experimental methicillin resistant Staphylococcus aureus sepsisBalancing Innate Immunity and Inflammatory State via Modulation of Neutrophil Function: A Novel Strategy to Fight SepsisThe importance of the granulocyte-colony stimulating factor in oncologyMicroglia-Mediated Neuroinflammation and Neurotrophic Factor-Induced Protection in the MPTP Mouse Model of Parkinson's Disease-Lessons from Transgenic MiceGM-CSF: An immune modulatory cytokine that can suppress autoimmunityGranulocyte colony-stimulating factor and reproductive medicine: A reviewMacrophages: An Inflammatory Link Between Angiogenesis and Lymphangiogenesis.Voriconazole: a new triazole antifungal.Granulocyte colony-stimulating factor improves deficient in vitro neutrophil transendothelial migration in patients with advanced liver disease.Comparative safety of filgrastim versus sargramostim in patients receiving myelosuppressive chemotherapy.Use of cytokines in human immunodeficiency virus-infected patients: colony-stimulating factors, erythropoietin, and interleukin-2.Adjunctive immune therapy for fungal infections.Immunomodulatory therapy in yeast infections.Agents under investigation for the treatment and prevention of neutropenia.Induction of Protective Immunity to Cryptococcal Infection in Mice by a Heat-Killed, Chitosan-Deficient Strain of Cryptococcus neoformans.Toll-Like Receptor 9 Activation Rescues Impaired Antibody Response in Needle-free Intradermal DNA VaccinationA new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity.Pivotal Cytoprotective Mediators and Promising Therapeutic Strategies for Endothelial Progenitor Cell-Based Cardiovascular Regeneration.Antifungal activities of posaconazole and granulocyte-macrophage colony-stimulating factor ex vivo and in mice with disseminated infection due to Scedosporium prolificans.Granulocyte colony-stimulating factor (GCSF) fused with Fc Domain produced from E. coli is less effective than Polyethylene Glycol-conjugated GCSF.Nano-curcumin safely prevents streptozotocin-induced inflammation and apoptosis in pancreatic beta cells for effective management of Type 1 diabetes mellitus.Acetylation impacts Fli-1-driven regulation of granulocyte colony stimulating factor.Aspergillosis in solid organ transplantation.Effects of adjunctive treatment with combined cytokines in a neutropenic mouse model of multidrug-resistant Enterococcus faecalis septicemia.Mobilization of dendritic cells in cancer patients treated with granulocyte colony-stimulating factor and chemotherapy.Granulocyte-colony stimulating factor controls neural and behavioral plasticity in response to cocaine.Granulocyte colony-stimulating factor gene rs1042658 variant and susceptibility to idiopathic recurrent pregnancy loss: A case-control study.
P2860
Q24200397-6120E859-32C7-4E25-836D-4CDB6F1A3785Q24240046-C5624047-1FC9-48B2-83B9-190EBDB4FFE3Q24243424-CA288577-C237-4138-94A3-256F763D8AD2Q24807217-BC5AAB3C-4E9F-4612-8EC8-D07528444773Q26769674-F3CC603A-D9C0-4904-830E-51D774E4E57EQ26770908-5723403F-4705-415B-9B44-D0B488FE9F2DQ26773064-5F0CCC03-CFA5-4474-B5CE-F15F832775ACQ28080640-1B23641E-D254-4FF1-904D-EEA7D2155D72Q28082481-80296088-8C4E-4736-BFE5-BEED2BF0332FQ30278005-D4339DAA-61E6-45E2-8029-5873CE70ADCEQ33917339-209A9942-2AB4-4316-ABA8-08C703396FBDQ33942743-0F331002-32C7-46C1-832B-B002303E7ACAQ34113758-C416FDAF-6B1C-416B-B755-E1289B03E286Q34169269-DF049787-5B09-4D7E-AB83-5A7043EB535EQ34350401-425E8EB7-902B-4ACC-A3CC-5215862DD638Q36723814-A3EB44D8-755D-4411-B4B3-463EA1763E7FQ36985881-7E60349F-08E2-4CDE-82CD-6AE8F8FF457FQ37123421-4D4976B3-5ACA-45F4-B40C-C0D1F82E348AQ37277900-E381C7A1-565D-4A04-918F-78513E55A025Q37381703-1D13F29F-4C8E-4CF3-BF56-A7E0E34FDB32Q37549578-7120E306-7D04-446D-AEC8-CAF520AB58BAQ37568516-CD06D5C1-5FCA-46C9-ACF3-0C4C6E71E68DQ38696361-044233CD-9D71-434C-BEA4-AF6569023427Q38837001-5460E1F8-632D-4B01-9593-D2C8E0696ABCQ41641093-7B3EF677-B1D7-412F-9B4A-CE6BAEBF8BE4Q42272291-7E5EA5B6-CB56-4F08-BB36-6FA06D759142Q43544840-DA00C0E4-DD41-470A-85CC-24D31030C129Q44163505-91DBA4F0-03BA-421C-A781-6B5123AAEBE4Q47861165-C4851F71-F81D-4C5A-BCC3-E4742F128A5FQ55395111-C3857219-728E-46BC-A98B-663C850F7321
P2860
Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Granulocyte colony-stimulating ...... ns in nonneutropenic patients.
@ast
Granulocyte colony-stimulating ...... ns in nonneutropenic patients.
@en
Granulocyte colony-stimulating ...... ns in nonneutropenic patients.
@nl
type
label
Granulocyte colony-stimulating ...... ns in nonneutropenic patients.
@ast
Granulocyte colony-stimulating ...... ns in nonneutropenic patients.
@en
Granulocyte colony-stimulating ...... ns in nonneutropenic patients.
@nl
prefLabel
Granulocyte colony-stimulating ...... ns in nonneutropenic patients.
@ast
Granulocyte colony-stimulating ...... ns in nonneutropenic patients.
@en
Granulocyte colony-stimulating ...... ns in nonneutropenic patients.
@nl
P356
P1476
Granulocyte colony-stimulating ...... ns in nonneutropenic patients.
@en
P304
P356
10.1086/513857
P407
P478
179 Suppl 2
P577
1999-03-01T00:00:00Z